Christopher J Brady1, Samantha D'Amico2, J Peter Campbell3. 1. Division of Ophthalmology, Department of Surgery, Larner College of Medicine, University of Vermont, Burlington, Vermont. 2. Division of Ophthalmology, Department of Surgery, University of Vermont Medical Center, Burlington, Vermont. 3. Casey Eye Institute, Oregon Health and Science University, Portland, Oregon.
Abstract
Background: Retinopathy of prematurity (ROP) is a disease of the retinal vasculature that remains a leading cause of childhood blindness worldwide despite improvements in the systemic care of premature newborns. Screening for ROP is effective and cost-effective, but in many areas, access to skilled examiners to conduct dilated examinations is poor. Remote screening with retinal photography is an alternative strategy that may allow for improved ROP care. Methods: The current literature was reviewed to find clinical trials and expert consensus documents on the state-of-the-art of telemedicine for ROP. Results: Several studies have confirmed the utility of telemedicine for ROP. In addition, several clinical studies have reported favorable long-term results. Many investigators have reinforced the need for detailed protocols on image acquisition and image interpretation. Conclusions: Telemedicine for ROP appears to be a viable alternative to live ophthalmoscopic examinations in many circumstances. Standardization and documentation afforded by telemedicine may provide additional benefits to providers and their patients. With continued improvements in image quality and affordability of imaging systems as well as improved automated image interpretation tools anticipated in the near future, telemedicine for ROP is expected to play an expanding role for a uniquely vulnerable patient population.
Background: Retinopathy of prematurity (ROP) is a disease of the retinal vasculature that remains a leading cause of childhood blindness worldwide despite improvements in the systemic care of premature newborns. Screening for ROP is effective and cost-effective, but in many areas, access to skilled examiners to conduct dilated examinations is poor. Remote screening with retinal photography is an alternative strategy that may allow for improved ROP care. Methods: The current literature was reviewed to find clinical trials and expert consensus documents on the state-of-the-art of telemedicine for ROP. Results: Several studies have confirmed the utility of telemedicine for ROP. In addition, several clinical studies have reported favorable long-term results. Many investigators have reinforced the need for detailed protocols on image acquisition and image interpretation. Conclusions: Telemedicine for ROP appears to be a viable alternative to live ophthalmoscopic examinations in many circumstances. Standardization and documentation afforded by telemedicine may provide additional benefits to providers and their patients. With continued improvements in image quality and affordability of imaging systems as well as improved automated image interpretation tools anticipated in the near future, telemedicine for ROP is expected to play an expanding role for a uniquely vulnerable patient population.
Authors: Michael F Chiang; Jeremy D Keenan; Justin Starren; Yunling E Du; William M Schiff; Gaetano R Barile; Joan Li; Rose Anne Johnson; Ditte J Hess; John T Flynn Journal: Arch Ophthalmol Date: 2006-03
Authors: Kelly C Wade; Maxwell Pistilli; Agnieshka Baumritter; Karen Karp; Alice Gong; Alex R Kemper; Gui-Shuang Ying; Graham Quinn Journal: J Pediatr Date: 2015-08-20 Impact factor: 4.406
Authors: James M Brown; J Peter Campbell; Andrew Beers; Ken Chang; Susan Ostmo; R V Paul Chan; Jennifer Dy; Deniz Erdogmus; Stratis Ioannidis; Jayashree Kalpathy-Cramer; Michael F Chiang Journal: JAMA Ophthalmol Date: 2018-07-01 Impact factor: 7.389
Authors: Samir N Patel; Maria Ana Martinez-Castellanos; David Berrones-Medina; Ryan Swan; Michael C Ryan; Karyn E Jonas; Susan Ostmo; J Peter Campbell; Michael F Chiang; R V Paul Chan Journal: Ophthalmology Date: 2017-04-03 Impact factor: 12.079
Authors: Steven L Morrison; Dmitry Dukhovny; R V Paul Chan; Michael F Chiang; J Peter Campbell Journal: JAMA Ophthalmol Date: 2022-04-01 Impact factor: 8.253